> Technologies 2010
BioVaria's technologies are presented as an all-day poster exhibition that enables industry prepresentatives to gain a unique overview of indiscovered, licensable technologies and to discuss scientific details face-to-face with the inventors.
Addionally half of the technologies (marked with a *) will also be presented as 10-min talks.
| Cardiovascular | |
| > K4 |
Prof. Håvard Attramadal, Dr M. Shakil Ahmed, Dr Vladimir N. Martinov, Prof. Guro Valen, Dr Ingvild Tronstad Moe |
| > P2* | miR-126 confers vascular protection - microRNA-126 for atherosclerosis protection and tissue repair Prof. Christian Weber, Dr Alma Zernecke, Dr Kiril Bidzhekov |
| > P3 | CCL17 as new therapeutic approach in Th1-driven diseases Prof. Christian Weber, Dr Alma Zernecke |
| Drug Delivery | |
| > E1* | Hepatitis B virus peptides as vehicles for specific delivery of compounds to the liver Prof. Stephan Urban |
| > U2* |
Prof. Wolfgang Lüke, Dr Heiko Manninga |
| Drug Development | |
| > E3 |
Prof. Peter Nawroth, Dr Angelika Bierhaus |
| > E4 | A new peptide for therapy of cardiac and/or skeletal muscle dysfunction Prof. Patrick Most, Prof. Hugo Katus |
| > M1* | Novel, highly selective inhibitors of CDK9 Dr Jan Eickhoff, Dr Peter Nussbaumer, Dr Gerd Rühter, Dr Carsten Schultz-Fademrecht |
| > P1* | Pellicious - Self-coating of lipid pellets by an extrusion/spheronisation process Prof. Joerg Breitkreutz, Dr Julia Matilainen |
| > P5 | NODinh - Novel specific NOD2 inhibitors with anti-inflammatory properties Dr Thomas Kufer, Prof. Hans-Günther Schmalz, Prof. Martin Krönke, Dr Janna Velder |
| Immune/Autoimmune | |
| > B1* | Blockade of IL-3 is a promising novel strategy for arthritis therapy Prof. Matthias Mack, Dr Hilke Brühl |
| > B2* | New isoform of the transcription factor RUNX1 (AML1) Prof. Stefan Gattenlöhner |
| > B4 | Lactocepin in the treatment of IP-10 mediated inflammatory diseases Prof. Dirk Haller, Gabriele Hörmannsperger |
| > B5 |
Dr Peter Biberthaler, Dr Viktoria Bogner, Dr Thomas Giese |
| > L2* | CEACAM8: Promising therapeutic agent with pleitropic effects Dr Bernhard B. Singer |
| Infection | |
| > A4 | Four highly potent adjuvants for mucosally administrable vaccines Prof. Carlos A. Guzman, Dr Thomas Ebensen, Dr Michael Morr |
| > A5 | Octapeptide PARF as diagnostic marker associated with rheumatic fever Dr Patric Nitsche-Schmitz, Dr Katrin Dinkla, Dr Vanessa Barroso, Prof. Gursharan S. Chhatwal |
| > A7 | Treatment of sepsis with MALP-2 Prof. Thomas Tschernig, Dr Tanja Barkhausen, Prof. Peter Mühlradt |
| > I1* | Novel pyrimidine derivatives for the treatment of picorna viral infections Dr Vadim Makarov, Prof. Peter Wutzler, Dr Michaela Schmidtke, Dr Hans-Martin Dahse |
| > K5 |
Prof. Torbjørn Omland, Dr Helge Røsjø, Prof. Geir Christensen, Prof. Mats Stridsberg |
| > L1* | Modulation of production of retroviruses by APOBEC4 Dr Carsten Münk, Mario Perkovic, Klaus Cichutek, Daniela Marino |
| > L4 | Immortalized human cell line for HIV phenotyping Dr Barbara Schnierle, Dr Doris Binninger-Schinzel, Albrecht Werner |
| > S4 | New peptides against drug-resistant HIV-1 strains Dr Gilles Divita, Dr Edwige Gros, Dr Audrey Agopian |
| > U1* |
Prof. Götz Nowak |
| > W2* | New target for the treatment of bacterial infections Prof. Sylvia Knapp, Dr Ulrich Matt, Dr Omar Sharif |
| Metabolism | |
| > B3 | High-throughput method for the analysis of fatty acid composition in plasma Claudia Glaser, Dr Hans Demmelmair, Prof. Berthold Koletzko |
| > K3 |
Prof. Arild Rustan, Dr Eili Tranheim Kase, Prof. Hege Thoresen, Prof. Jo Klaveness, Prof. Pål Rongved |
| > N2 | New candidate gene for diagnostic and therapeutic development to combat obesity-associated diabetes Prof. Hans-Georg Joost, Dr Reinhart Kluge, Matthias Nestler, Dr Stephan Scherneck, Prof. Annette Schürmann |
| Neurological Disorders | |
| > A2* | New targets and related peptides for diagnostic use and treatment of Complex Regional Pain Syndrom Prof. Franz Blaes, Dr Gerd Wallukat |
| > K2* |
Prof. Ole Petter Ottersen, Dr Mahmood Reza Amiry-Moghaddam, Prof. Jo Klaveness, Prof. Pål Rongved, Dr Øyvind Jacobsen |
| > L5 | Methods and substances for the treatment of Alzheimer’s Disease Dr Christian Buchholz, Dr Ulrich Kalinke, Patricia Bach, Prof. Ulrike Müller |
| > L6 | Small C3bot peptides for the treatment of traumatic or degenerative meuronal injuries Prof. Gudrun Ahnert-Hilger, Dr Markus Höltje, Dr Gisela Große, Prof. Ingo Just, Dr Fred Hofmann |
| > S5 | New drug against Parkinson disease Dr Bruno Figadere, Dr Fanny Schmidt, Dr Rita Sylvia Raisman-Vozari, Dr Pierre Champy, Dr Xavier Franck |
| Oncology | |
| > E2 | FGF2 phosphorylation by Tec Kinase is required for FGF2 secretion Prof. Walter Nickel, Dr Rainer Pepperkok, Dr Antje Ebert, Sabine Wegehingel |
| > E6 |
Dr Michael Hundemer, Dr Olaf Christensen |
| > F1* |
Dr Andreas Schubert |
| > L7 | Combination therapy: Combined application of chimeric toxins and saponins Dr Hendrik Fuchs, Dr Mark Sutherland, Christopher Bachran, Dr Iring Heisler, Prof. Matthias Melzig |
| > N1* |
Jan Christoph Brase, Dr Holger Sültmann, Dr Ruprecht Kuner, Dr Thorsten Schlomm |
| > S1* | New multi-target epigenetic anti-cancer drug Dr Hinrich Gronemeyer, Dr Angel De Lera, Prof. Lucia Altucci, Prof. Henk Stunnenberg |
| > S3 |
Dr Bohdan Wasylyk, Prof. Jack Schalken, Dr Gabri van de Pluijm |
| Others | |
| > A6 | Derivation of vector-free induced pluripotent stem (iPS) cells using site-specific DNA recombination Dr Ralf Kühn, Prof. Wolfgang Wurst |
| Tools | |
| > A1* |
Dr Zoltan Ivics, Dr Zsuzsanna Izsvak, Dr Mates Lajos |
| > A3* | Iterative Chip-Based Cytometry (iCBC) Dr Christian Hennig, Prof. Gesine Hansen |
| > E5 | New senescence marker for cell-culture Dr Wolfgang Wagner, Dr Patrick Horn |
| > K1* | Artificial enzymes - polymer bound organocatalysts Dr Tor Erik Holt Kristensen, Dr Tore Hansen, Prof. Finn Knut Hansen |
| > L3* | Enabling technology: Direct assessment of cytotoxic T cell function Jonas Stanke, Corinna Hoffmann, Dr Andreas Kaufmann |
| > P4 |
Dr Jonathan West, Jean-Philippe Frimat, Julia I. Sisnaiske, Dr Christoph van Thriel, Prof. Jan G. Hengstler |
| > S2* | Protein chips: Amphipols as universal adapters to immobilize membrane proteins onto solid supports Dr Jean-Luc Popot, Dr Delphine Charvolin, Dr Fabrice Giusti |
| > W1* | Improved protein production in mammalian cells Dr Anton Bauer, Dr Emilio Casanova, Leander Blaas |